Drug & Medication
Summary
Data Series
Introduction This model contains a ten year commercial forecast of hepatitis B drug sales by country, class, molecule and brand across the US, Japan, France, Germany, Italy, Spain, UK and Turkey. Reasons to Purchase *Understand the changing market dynamics of hepatitis B drugs and success factors for leading brands. *Assess the impact of events such as patent expiries on the overall hepatitis B market....
More »Search ReportLinker
The Largest Collection of Market Research Reports
From +200,000 authoritative sources
Talk to Alison
00 1 718 618 48 97
This market research report package offers a perspective on the actual market situation, trends and future outlook for vaccines in different countries around the world. The studies provide essential market ...
This report is an effort to identify factors, which will be the driving force for the infertility drugs and devices market and sub-markets in the next few years. The report provides an extensive analysis ...
This triple analysis focuses on cancer drug development strategies by the two mechanism/target/effect areas of Angiogenesis and Cancer Vaccines and by the compound strategy of Peptides. Each of these three ...
... Use internally as part of a monthly cleansing regimen for gi health antibiotic, anti-inflammatory, antibacterial, antifungal, antioxidant, anti-parasitic, antiviral, disinfectant candida cleanse ...
... Antiosteoporosic drugs - casula m, filippi a, flacco e, gambera m, manzoli l, menditto e, orlando v, piccinelli r, tragni e, catapano a. Assessment and potential determinats of compliance and persistence to anti ...
... Clinical regulatory toxicology phase i clinical phase ii clinical diabetes inflammation oncology (non-cytotoxic) anti-infectives clotting disorders obesity cns nce pipeline nce pipeline tyrosine-tzd, non ...
United Kingdom
United States
Europe
Japan
Germany
France
Italy
Spain
ref:plp2010
Reportlinker.com © Copyright 2013. All rights reserved.